[
    "{\"step_by_step_thinking\": \"CGRP (calcitonin gene-related peptide) is a neuropeptide that has been implicated in the pathophysiology of migraine. Currently, there are small molecule CGRPs under development for the treatment of migraine. These small molecules are designed to target and inhibit the CGRP receptor, thereby reducing the frequency and severity of migraine attacks. Therefore, the answer is yes.\", \"answer_choice\": \"A\"}"
]